Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1986 Jan;87(1):279–283. doi: 10.1111/j.1476-5381.1986.tb10181.x

Anaesthesia abolishes the effect of valproate on extracellular 5-HIAA, DOPAC and ascorbate as measured in rat striatum by differential pulse voltammetry.

F Crespi, P E Keane, M Morre
PMCID: PMC1916909  PMID: 2420401

Abstract

The effect of sodium valproate (VPA, 400 mg kg-1, i.p.) on extracellular ascorbate, 3,4-dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindoleacetic acid (5-HIAA) in the striatum was examined by differential pulse voltammetry in anaesthetized and freely-moving rats. In rats anaesthetized with chloral hydrate (400 mg kg-1, i.p.) pentobarbitone (50 mg kg-1, i.p.) or phenobarbitone (60 mg kg-1, i.p.), VPA produced no significant changes in peak 1 (extracellular ascorbate) or peak 2 (extracellular DOPAC), but produced a slight but statistically significant reduction in the height of peak 3 (extracellular 5-HIAA). In contrast, in freely-moving rats the same dose of VPA greatly reduced extracellular ascorbate and DOPAC concentrations, and increased that of 5-HIAA. These results suggest that VPA may reduce the release or turnover of dopamine, and increase that of 5-hydroxytryptamine in conscious rats. Our data also suggest that caution may be required in the interpretation of the effects of VPA in anaesthetized animals, as the results obtained may not always reflect the situation in the absence of anaesthesia.

Full text

PDF
279

Images in this article

280Figure 1
on p.280

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chapman A. G., Meldrum B. S., Mendes E. Acute anticonvulsant activity of structural analogues of valproic acid and changes in brain GABA and aspartate content. Life Sci. 1983 Apr 25;32(17):2023–2031. doi: 10.1016/0024-3205(83)90054-1. [DOI] [PubMed] [Google Scholar]
  2. Chapman A., Keane P. E., Meldrum B. S., Simiand J., Vernieres J. C. Mechanism of anticonvulsant action of valproate. Prog Neurobiol. 1982;19(4):315–359. doi: 10.1016/0301-0082(82)90010-7. [DOI] [PubMed] [Google Scholar]
  3. Clemens J. A., Phebus L. A. Brain dialysis in conscious rats confirms in vivo electrochemical evidence that dopaminergic stimulation releases ascorbate. Life Sci. 1984 Aug 6;35(6):671–677. doi: 10.1016/0024-3205(84)90262-5. [DOI] [PubMed] [Google Scholar]
  4. Crespi F., Jouvet M. Differential pulse voltammetric determination of 5-hydroxyindoles in four raphe nuclei of chronic freely moving rats simultaneously recorded by polygraphic technique: physiological changes with vigilance states. Brain Res. 1984 May 7;299(1):113–119. doi: 10.1016/0006-8993(84)90793-5. [DOI] [PubMed] [Google Scholar]
  5. Crespi F., Paret J., Keane P. E., Morre M. An improved differential pulse voltammetry technique allows the simultaneous analysis of dopaminergic and serotonergic activities in vivo with a single carbon-fibre electrode. Neurosci Lett. 1984 Nov 23;52(1-2):159–164. doi: 10.1016/0304-3940(84)90367-7. [DOI] [PubMed] [Google Scholar]
  6. Fletcher A., Harding V. An examination of the 'wet dog' shake behaviour in rats produced by acute administration of sodium n-dipropylacetate. J Pharm Pharmacol. 1981 Dec;33(12):811–813. doi: 10.1111/j.2042-7158.1981.tb13945.x. [DOI] [PubMed] [Google Scholar]
  7. Godin Y., Heiner L., Mark J., Mandel P. Effects of DI-n-propylacetate, and anticonvulsive compound, on GABA metabolism. J Neurochem. 1969 Jun;16(3):869–873. doi: 10.1111/j.1471-4159.1969.tb08975.x. [DOI] [PubMed] [Google Scholar]
  8. Gonon F., Buda M., Cespuglio R., Jouvet M., Pujol J. F. In vivo electrochemical detection of catechols in the neostriatum of anaesthetized rats: dopamine or DOPAC? Nature. 1980 Aug 28;286(5776):902–904. doi: 10.1038/286902a0. [DOI] [PubMed] [Google Scholar]
  9. Gonon F., Buda M., Cespuglio R., Jouvet M., Pujol J. F. Voltammetry in the striatum of chronic freely moving rats: detection of catechols and ascorbic acid. Brain Res. 1981 Oct 26;223(1):69–80. doi: 10.1016/0006-8993(81)90807-6. [DOI] [PubMed] [Google Scholar]
  10. Horton R. W., Anlezark G. M., Sawaya M. C., Meldrum B. S. Monoamine and GABA metabolism and the anticonvulsant action of di-n-propylacetate and ethanolamine-O-sulphate. Eur J Pharmacol. 1977 Feb 21;41(4):387–397. doi: 10.1016/0014-2999(77)90259-x. [DOI] [PubMed] [Google Scholar]
  11. Hwang E. C., Van Woert M. H. Effect of valproic and acid on serotonin metabolism. Neuropharmacology. 1979 Apr;18(4):391–397. doi: 10.1016/0028-3908(79)90147-3. [DOI] [PubMed] [Google Scholar]
  12. Keller H. H., Schaffner R., Haefely W. Interaction of benzodiazepines with neuroleptics at central dopamine neurons. Naunyn Schmiedebergs Arch Pharmacol. 1976 Jul;294(1):1–7. doi: 10.1007/BF00692778. [DOI] [PubMed] [Google Scholar]
  13. Lazarova M., Roussinov K., Kleinrok Z., Rajtar G. On some relationships between GABA-ergic and 5-HT-ergic mechanisms in pentylenetetrazol convulsive-seizure reactions. Agressologie. 1980;21(5):253–257. [PubMed] [Google Scholar]
  14. O'Neill R. D., Fillenz M., Sundstrom L., Rawlins J. N. Voltammetrically monitored brain ascorbate as an index of excitatory amino acid release in the unrestrained rat. Neurosci Lett. 1984 Dec 21;52(3):227–233. doi: 10.1016/0304-3940(84)90166-6. [DOI] [PubMed] [Google Scholar]
  15. Pinder R. M., Brogden R. N., Speight T. M., Avery G. S. Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs. 1977 Feb;13(2):81–123. doi: 10.2165/00003495-197713020-00001. [DOI] [PubMed] [Google Scholar]
  16. Scatton B., Serrano A., Rivot J. P., Nishikawa T. Inhibitory GABAergic influence on striatal serotonergic transmission exerted in the dorsal raphe as revealed by in vivo voltammetry. Brain Res. 1984 Jul 9;305(2):343–352. doi: 10.1016/0006-8993(84)90440-2. [DOI] [PubMed] [Google Scholar]
  17. Scatton B., Zivkovic B., Dedek J., Lloyd K. G., Constantinidis J., Tissot R., Bartholini G. gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas. J Pharmacol Exp Ther. 1982 Mar;220(3):678–688. [PubMed] [Google Scholar]
  18. Schechter P. J., Tranier Y., Grove J. Effect of n-dipropylacetate on amino acid concentrations in mouse brain: correlations with anti-convulsant activity. J Neurochem. 1978 Nov;31(5):1325–1327. doi: 10.1111/j.1471-4159.1978.tb06258.x. [DOI] [PubMed] [Google Scholar]
  19. Spano P. F., Neff N. H. Metabolic fate of caudate nucleus dopamine. Brain Res. 1972 Jul 13;42(1):139–145. doi: 10.1016/0006-8993(72)90048-0. [DOI] [PubMed] [Google Scholar]
  20. Trulson M. E., Trulson V. M. Chloral hydrate anesthesia alters the responsiveness of dorsal raphe neurons to psychoactive drugs. Life Sci. 1983 Feb 28;32(9):949–956. doi: 10.1016/0024-3205(83)90924-4. [DOI] [PubMed] [Google Scholar]
  21. Whitton P. S., Oresković D., Marković Z., Skarpa D., Bulat M. Effect of the antiepileptic di-n-propylacetamide on 5-hydroxytryptamine turnover in the brain and 5-hydroxyindoleacetic acid level in the cerebrospinal fluid. Eur J Pharmacol. 1983 Jul 15;91(1):57–62. doi: 10.1016/0014-2999(83)90361-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES